A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma-Reference-Cited by-同舟云学术

A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma

Published:2013-01-29 Issue:2 Volume:161 Page:183-191
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Budde Lihua E.,Zhang Michelle M.¹,Shustov Andrei R.,Pagel John M.,Gooley Ted A.,Oliveira George R.²,Chen Tara L.³,Knudsen Nancy L.⁴,Roden Jennifer E.⁵,Kammerer Britt E.⁴,Frayo Shani L.⁴,Warr Thomas A.⁶,Boyd Thomas E.⁷,Press Oliver W.,Gopal Ajay K.

Affiliation:

1. Valley Medical Center; Renton; WA; USA

2. Department of Radiology; Massachusetts General Hospital; Boston; MA; USA

3. Pharmacy Services; University of Washington; Seattle; WA; USA

4. Clinical Research Dvision; Fred Hutchinson Cancer Research Center; Seattle; WA; USA

5. Department of Medicine; University of Washington; Seattle; WA; USA

6. Great Falls Clinic; Great Falls; MT; USA

7. Yakima Regional Medical & Cardiac Center; Yakima; WA; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12230/fullpdf

Reference28 articles.

1. Early-stage Hodgkin's lymphoma;Armitage;The New England Journal of Medicine,2010

2. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,1999

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;The New England Journal of Medicine,2002

4. A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors;Dickson;Investigational New Drugs,2011

5. Targeting tumor angiogenesis with histone deacetylase inhibitors;Ellis;Cancer Letters,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells;American Journal of Cancer Research;2024

2. Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents;Journal of Hematology & Oncology;2023-08-25

3. Clinical advances in epigenetic therapies for lymphoma;Clinical Epigenetics;2023-03-04

4. Epigenetic targets in B- and T-cell lymphomas: latest developments;Therapeutic Advances in Hematology;2023-01

5. Ibrutinib combined with low‐dose histone deacetylases inhibitor chidamide synergistically enhances the anti‐tumor effect in B‐cell lymphoma;Hematological Oncology;2022-08-24